Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children
Clinical Medicine Insights: Pediatrics · 2024-01 · 18
DOI: 10.1177/11795565241236176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Insights: Pediatrics, online erschienen am 06.03.2024. Verfasst von Sabeen Abid Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shifa College of Medicine, Tameer-e-Millat University, Islamabad, Pakistan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Hereditary Tyrosinemia Type 1 (HT1), a rare autosomal recessive metabolic disorder, arises from fumarylacetoacetate (FAH) enzyme deficiency, resulting in toxic metabolite buildup. It manifests in acute, subacute, and chronic forms, with early diagnosis and Nitisinone treatment being vital.
Objectives
The study aims to highlight the different clinical presentations of Hereditary Tyrosinemia type 1 in a cohort of Pakistani children.
Design
Retrospective observational study. Methodology: All patients diagnosed with HT1 at Shifa International Hospital, Islamabad and Pak Emirates Military Hospital, Rawalpindi between 2010 and 2023 were included. Information was collected regarding age, gender, symptoms, physical signs, and laboratory results.
Results
The study identified 6 cases of HT1. The average age at presentation was 8 months, with a mean delay in diagnosis of 26.8 months. Males were 4 (66.7%) and 2 (33.3%) were females. All patients had underlying liver disease presenting as abdominal distension with hepatosplenomegaly and accompanying growth failure. Four cases presented with rickets, 2 of which had hypophosphatemic rickets. Urine for succinylacetone was raised in all patients. Alpha fetoprotein was raised but hepatocellular carcinoma was diagnosed in 1 patient only. Low protein diet, and vitamin supplements were used for management. Five of the 6 patients died within 2 years of diagnosis.
Conclusion
Delayed referrals and unavailability of Nitisinone are the major challenges in diagnosing and treating HT1 in Pakistan.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shifa College of Medicine, Tameer-e-Millat University, Islamabad, Pakistan.
- Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan.
ORCID-Profile: Sabeen Abid Khan, Misbah Fakih, Nida Taufiq
Zitieren
APA
Khan, S. A., Fakih, M., Taufiq, N., Ahmerin, A., Bangash, A., & Iqbal Malik, M. (2024). Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children. Clinical Medicine Insights: Pediatrics, 18. https://doi.org/10.1177/11795565241236176
Vancouver
Khan SA, Fakih M, Taufiq N, Ahmerin A, Bangash A, Iqbal Malik M. Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children. Clinical Medicine Insights: Pediatrics. 2024;18. doi:10.1177/11795565241236176
BibTeX
@article{Khan2024,
author = {Khan, Sabeen Abid and Fakih, Misbah and Taufiq, Nida and Ahmerin, Afaaf and Bangash, Asfand and Iqbal Malik, Munir},
title = {Clinical Spectrum of Hereditary Tyrosinemia Type 1 in a Cohort of Pakistani Children},
journal = {Clinical Medicine Insights: Pediatrics},
year = {2024},
volume = {18},
doi = {10.1177/11795565241236176}
}
EUVIMED